WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China's Clinical Trial Quality Management Faces Key Challenges Despite Progres... A recent systematic review published in Frontiers in Medicine examines the evolution of clinical trial quality management in China, highlighting both advances and challen...
(9/2/2025)

NHSA Issues the Regulations on DRG/DIP Healthc... (9/13/2025)

The Rise of US-China Biotech Partnerships: Opp... (9/12/2025)

U.S. Drugmakers Warn White House of Chaos as T... (9/10/2025)

How China Seeks to Solve Its Quality Control C... (9/5/2025)

China Biopharma Tracker – August 2025 (Pharma... (9/3/2025)

China's Biopharma Industry Clusters: Mapping O... (9/3/2025)

China's Clinical Trial Quality Management Face... (9/2/2025)

AstraZeneca Bounces Back from Scandal in China... (8/27/2025)

Global Pharma Funnels $48.5B into Chinese Biot... (8/27/2025)

Premier Li Visits BeOne, Signaling China's Str... (8/22/2025)

On the Cusp of a Cure: Is Asia Pacific Ready f... (8/20/2025)

Six Key Insights Into China Biotech's NewCo Mo... (8/19/2025)

Bayer Expands China Presence with New In... (9/13/2025) China to Incorporate HPV Vaccines into N... (9/13/2025) Nanjing's Triastek Builds World's Larges... (9/13/2025) CDE Seeks Public Opinions on New HIV/AID... (9/13/2025) CDE Releases New, Comprehensive Guidelin... (9/13/2025) CDE Introduces New Risk Management Guide... (9/13/2025) CDE Releases First Technical Guidelines ... (9/13/2025) Denovo's Publishes Landmark Trial in Pre... (9/13/2025) NMPA Releases 96th Batch of Reference Fo... (9/13/2025) China NMPA Drastically Shortens Drug Tri... (9/12/2025) China Approves FirboX's Fibroblast-Based... (9/12/2025) CDE Seeks Feedback on Draft Guidance for... (9/12/2025) CDE Solicits Input on Draft Guidance for... (9/12/2025) CDE Seeks Feedback on Draft Guidance for... (9/12/2025) CDE Solicits Comments on Draft Guidance ... (9/12/2025) U.S. House Passes Bill That Could Sever ... (9/12/2025) RabPharma Raises Oversubscribed Series A... (9/11/2025) Novartis Gains Expanded Approval for Tab... (9/11/2025)

China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M... China Drives Asia-Pacific Health Care Transformation Am... China's Innovative Drug Market Surpasses CNY 400 Billio... China's 'Silver Yuan' Set to Power US$134B Boom in Geri...

Nanjing's Triastek Builds World's Largest 3D-Printed Ph... Bayer Expands China Presence with New Innovation Platfo... Chinese Biotechs Face Rising Hurdles in Advanced Therap... HKU-Med, GBAICTI and GSK Join Forces to Boost Real-Worl... RabPharma Raises Oversubscribed Series A++ to Push Ahea...

NMPA Releases 96th Batch of Reference Formulations for ... CDE Releases First Technical Guidelines for GLP-1 Drugs CDE Introduces New Risk Management Guidelines for Innov... CDE Releases New, Comprehensive Guidelines for Innovati... CDE Seeks Public Opinions on New HIV/AIDS Drug Guidelin...

China to Incorporate HPV Vaccines into National Immuniz... NHSA Seeks Feedback on Draft Implementation Rules for M... Aon Report Highlights Rapid Growth and Challenges in Ch... NHSA Announces Results of Form Review for 2025 NRDL Sub... China Unveils Nine Key Healthcare Insurance Priorities ...

Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C... U.S. Lawmakers Raise Fresh Alarm Over GenScript's China... Record China Pharma Monopoly Fine Sends Strong Deterren...

India Moves to Set Minimum Import Prices to Protect Pha... China Struggles to Maintain Grip on India's Bulk Drug M... API China 2025 Ends with High Attendance and Global Ind... FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha...

Denovo's Publishes Landmark Trial in Precision Psychiat... China Approves FirboX's Fibroblast-Based Therapy for Cl... IDEAYA's IDE849 Shows Strong Results in Phase I Trial Henlius' HLX43 Shows Promising Results in Phase I Trial... Novartis Gains Expanded Approval for Tabrecta in China

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Official and Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...